<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>42(10)</volume><submitter>Rai KK</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>There is limited evidence on the economic burden of COVID-19 in Germany. This study aims to quantify healthcare resource utilisation (HCRU) and direct medical costs associated with COVID-19 in paediatrics in Germany.&lt;h4>Methods&lt;/h4>This was a population-based retrospective cohort study using data from the German Statutory Health Insurance (SHI) claims database to define outpatient (April 2020 to December 2021) and hospitalised (April 2020 to October 2022) cohorts of paediatric patients (aged 1-17 years) with a COVID-19 diagnosis.&lt;h4>Results&lt;/h4>In the outpatient cohort (n = 104,656), most (77%) patients had ≥ 2 COVID-19-related general practitioner (GP) visits and 29% had ≥ 1 specialist visit during their diagnosis quarter. Outpatient resource use was greater in high-r</pubmed_abstract><journal>Advances in therapy</journal><pagination>5072-5087</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12474641</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>COVID-19-Related Healthcare Resource Utilisation and Costs in Paediatric Patients in Germany: A Population-Based Study.</pubmed_title><pmcid>PMC12474641</pmcid><pubmed_authors>Rai KK</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Schmetz A</pubmed_authors><pubmed_authors>Gowman H</pubmed_authors><pubmed_authors>Massey L</pubmed_authors><pubmed_authors>Nguyen J</pubmed_authors><pubmed_authors>Seif M</pubmed_authors><pubmed_authors>Volkman H</pubmed_authors></additional><is_claimable>false</is_claimable><name>COVID-19-Related Healthcare Resource Utilisation and Costs in Paediatric Patients in Germany: A Population-Based Study.</name><description>&lt;h4>Introduction&lt;/h4>There is limited evidence on the economic burden of COVID-19 in Germany. This study aims to quantify healthcare resource utilisation (HCRU) and direct medical costs associated with COVID-19 in paediatrics in Germany.&lt;h4>Methods&lt;/h4>This was a population-based retrospective cohort study using data from the German Statutory Health Insurance (SHI) claims database to define outpatient (April 2020 to December 2021) and hospitalised (April 2020 to October 2022) cohorts of paediatric patients (aged 1-17 years) with a COVID-19 diagnosis.&lt;h4>Results&lt;/h4>In the outpatient cohort (n = 104,656), most (77%) patients had ≥ 2 COVID-19-related general practitioner (GP) visits and 29% had ≥ 1 specialist visit during their diagnosis quarter. Outpatient resource use was greater in high-r</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-03T21:32:01.984Z</modification><creation>2026-05-01T03:11:25.695Z</creation></dates><accession>S-EPMC12474641</accession><cross_references><pubmed>40788458</pubmed><doi>10.1007/s12325-025-03313-5</doi></cross_references></HashMap>